nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—Valrubicin—urinary bladder cancer	0.687	0.72	CbGbCtD
Pefloxacin—TOP2A—Epirubicin—urinary bladder cancer	0.104	0.109	CbGbCtD
Pefloxacin—TOP2A—Etoposide—urinary bladder cancer	0.0811	0.0849	CbGbCtD
Pefloxacin—TOP2A—Doxorubicin—urinary bladder cancer	0.0553	0.0579	CbGbCtD
Pefloxacin—CYP1A2—Fluorouracil—urinary bladder cancer	0.0149	0.0156	CbGbCtD
Pefloxacin—CYP1A2—Etoposide—urinary bladder cancer	0.0124	0.013	CbGbCtD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT5—urinary bladder cancer	0.00218	0.0545	CbGpPWpGaD
Pefloxacin—CYP1A2—Arylamine metabolism—NAT2—urinary bladder cancer	0.00178	0.0445	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—urinary bladder cancer	0.00132	0.033	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00123	0.0308	CbGpPWpGaD
Pefloxacin—TOP2A—G0 and Early G1—CCNE1—urinary bladder cancer	0.0011	0.0275	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00109	0.0273	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—urinary bladder cancer	0.00104	0.0259	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000884	0.0221	CbGpPWpGaD
Pefloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000776	0.0194	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000687	0.0172	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000667	0.0167	CbGpPWpGaD
Pefloxacin—TOP2A—Daunorubicin—Valrubicin—urinary bladder cancer	0.00065	0.125	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Valrubicin—urinary bladder cancer	0.00065	0.125	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Valrubicin—urinary bladder cancer	0.00065	0.125	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Valrubicin—urinary bladder cancer	0.00065	0.125	CbGdCrCtD
Pefloxacin—TOP2A—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000632	0.0158	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000584	0.0146	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—urinary bladder cancer	0.00051	0.0128	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—SMC1B—urinary bladder cancer	0.000496	0.0124	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00049	0.0123	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—urinary bladder cancer	0.000484	0.0121	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000476	0.0119	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000445	0.0111	CbGpPWpGaD
Pefloxacin—TOP2A—Teniposide—Etoposide—urinary bladder cancer	0.000434	0.0835	CbGdCrCtD
Pefloxacin—TOP2A—Podofilox—Etoposide—urinary bladder cancer	0.000434	0.0835	CbGdCrCtD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000424	0.0106	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000418	0.0105	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000405	0.0101	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000399	0.01	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.000398	0.00996	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—urinary bladder cancer	0.000388	0.00971	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000379	0.00948	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000379	0.00948	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000372	0.0093	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—MYC—urinary bladder cancer	0.000367	0.00918	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000365	0.00913	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—urinary bladder cancer	0.000359	0.00898	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000346	0.00867	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000343	0.00859	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000339	0.00849	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000337	0.00844	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.00031	0.00777	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—TP53—urinary bladder cancer	0.000301	0.00754	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	0.000285	0.00714	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000284	0.00712	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—urinary bladder cancer	0.00028	0.00701	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000279	0.00697	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000272	0.0068	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.00027	0.00675	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000261	0.00652	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ESPL1—urinary bladder cancer	0.000254	0.00636	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Gemcitabine—urinary bladder cancer	0.000244	0.047	CbGdCrCtD
Pefloxacin—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000234	0.00585	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00023	0.00577	CbGpPWpGaD
Pefloxacin—TOP2A—Idarubicin—Epirubicin—urinary bladder cancer	0.000226	0.0436	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Epirubicin—urinary bladder cancer	0.000226	0.0436	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Epirubicin—urinary bladder cancer	0.000226	0.0436	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000225	0.00562	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000225	0.00562	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000221	0.00554	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000221	0.00554	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000218	0.00547	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	0.000218	0.00546	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000216	0.00541	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000215	0.00539	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000215	0.00539	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000212	0.00531	CbGpPWpGaD
Pefloxacin—TOP2A—Epirubicin—Doxorubicin—urinary bladder cancer	0.000209	0.0403	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Doxorubicin—urinary bladder cancer	0.000209	0.0403	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000209	0.0403	CbGdCrCtD
Pefloxacin—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000207	0.00519	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000204	0.0051	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000203	0.00507	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000201	0.00504	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.0002	0.00501	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.0002	0.005	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.000194	0.00485	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—LIG1—urinary bladder cancer	0.000193	0.00482	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—STAG2—urinary bladder cancer	0.000193	0.00482	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	0.00019	0.00475	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000188	0.0047	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000182	0.00457	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—FAS—urinary bladder cancer	0.00018	0.00452	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00018	0.0045	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000177	0.00444	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Gemcitabine—urinary bladder cancer	0.000175	0.0337	CbGdCrCtD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	0.000167	0.00418	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000166	0.00416	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000166	0.00415	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000165	0.00414	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000165	0.00412	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000161	0.00403	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	0.000161	0.00402	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000159	0.00397	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RRM2—urinary bladder cancer	0.000159	0.00397	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000157	0.00393	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000154	0.00386	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000151	0.00378	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000144	0.00361	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000144	0.00361	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000143	0.00357	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	0.000141	0.00353	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	0.000136	0.00341	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000135	0.00338	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—SMC1A—urinary bladder cancer	0.000135	0.00338	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	0.000132	0.0033	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000121	0.00304	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000121	0.00303	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00012	0.003	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000118	0.00296	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000118	0.00296	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	0.000113	0.00283	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000111	0.00279	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000107	0.00267	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000105	0.00262	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000103	0.00259	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000103	0.00258	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000103	0.00257	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000102	0.00256	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—urinary bladder cancer	9.9e-05	0.00248	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	9.83e-05	0.00246	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	9.7e-05	0.00243	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	9.7e-05	0.00243	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.56e-05	0.00239	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—EP300—urinary bladder cancer	9.44e-05	0.00236	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	9.41e-05	0.00236	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCNE1—urinary bladder cancer	9.35e-05	0.00234	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TYMS—urinary bladder cancer	9.18e-05	0.0023	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	9.08e-05	0.00227	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	8.99e-05	0.00225	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.57e-05	0.00214	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	8.48e-05	0.00212	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.38e-05	0.0021	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.07e-05	0.00202	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	8.07e-05	0.00202	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	8.01e-05	0.002	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—urinary bladder cancer	8e-05	0.002	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.98e-05	0.002	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.92e-05	0.00198	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	7.85e-05	0.00196	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	7.85e-05	0.00196	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ATM—urinary bladder cancer	7.19e-05	0.0018	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK4—urinary bladder cancer	7.16e-05	0.00179	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.03e-05	0.00176	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	7.03e-05	0.00176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7e-05	0.00175	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	6.96e-05	0.00174	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	6.88e-05	0.00172	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	6.88e-05	0.00172	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—urinary bladder cancer	6.75e-05	0.00169	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	6.55e-05	0.00164	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	6.55e-05	0.00164	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	6.52e-05	0.00163	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	6.5e-05	0.00163	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.43e-05	0.00161	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RB1—urinary bladder cancer	6.22e-05	0.00156	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	6.12e-05	0.00153	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	5.99e-05	0.0015	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.91e-05	0.00148	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	5.52e-05	0.00138	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2A—urinary bladder cancer	5.47e-05	0.00137	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	5.17e-05	0.00129	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	5e-05	0.00125	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	4.76e-05	0.00119	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—urinary bladder cancer	4.62e-05	0.00116	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—urinary bladder cancer	4.47e-05	0.00112	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—EP300—urinary bladder cancer	4.26e-05	0.00107	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	4.15e-05	0.00104	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4e-05	0.001	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	3.79e-05	0.000948	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	3.79e-05	0.000948	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.73e-05	0.000932	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—urinary bladder cancer	3.71e-05	0.000928	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.46e-05	0.000867	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.12e-05	0.000781	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—urinary bladder cancer	3.05e-05	0.000762	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.95e-05	0.000737	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.87e-05	0.000718	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.3e-05	0.000576	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.29e-05	0.000574	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.2e-05	0.000552	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.08e-05	0.000519	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000448	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.66e-05	0.000415	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.66e-05	0.000415	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.65e-05	0.000413	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.61e-05	0.000403	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.58e-05	0.000397	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.34e-05	0.000335	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.3e-05	0.000325	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.13e-05	0.000283	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.000279	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.08e-05	0.00027	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.04e-05	0.00026	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	9.81e-06	0.000246	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	9.64e-06	0.000241	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	9.06e-06	0.000227	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	7.34e-06	0.000184	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.06e-06	0.000177	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.78e-06	0.000145	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.04e-06	0.000126	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.81e-06	0.00012	CbGpPWpGaD
